Wealthy countries
oxfam COVID vaccine supply report Rich countries corner nearly 51% supply of five major COVID-19 vaccine candidates: Oxfam

According to a recent study by Oxfam International, wealthy nations, which account for nearly 13% of the global population, have cornered a lion’s share of supply deals for vaccine candidates in phase-3 of the clinical trials